TCIIS
TEVA icon

TIAA-CREF Individual & Institutional Services’s Teva Pharmaceuticals TEVA Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
4,635
-292
-6% -$9.73K ﹤0.01% 711
2026
Q1 		$148K Buy
+4,927
New +$159K ﹤0.01% 674

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's TEVA Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services reduced its Teva Pharmaceuticals (TEVA) stake by 5.9% in Q2 2026, selling an estimated $9.73K and leaving 4,635 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

TIAA-CREF Individual & Institutional Services first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 4,635 shares of Teva Pharmaceuticals worth $157K as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services sold 292 Teva Pharmaceuticals shares in Q2 2026, an estimated $9.73K.
  • Teva Pharmaceuticals made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #711 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.